v3.26.1
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
Beginning Balance at Dec. 31, 2024 $ 151,970   $ 525,934 $ (374,227) $ 263
Beginning Balance, Shares at Dec. 31, 2024   49,998,279      
Stock-based compensation expense 3,514   3,514    
Employee Stock Purchase Plan issuance 96   96    
Employee Stock Purchase Plan issuance, Shares   15,263      
Vesting of restricted stock, Shares   211,770      
Unrealized loss on marketable securities (137)       (137)
Currency translation adjustment (21)       (21)
Other 27   27    
Net loss (27,483)     (27,483)  
Ending Balance at Mar. 31, 2025 127,966   529,571 (401,710) 105
Ending Balance, Shares at Mar. 31, 2025   50,225,312      
Beginning Balance at Dec. 31, 2025 136,913   617,433 (480,418) (102)
Beginning Balance, Shares at Dec. 31, 2025   63,587,777      
Stock-based compensation expense 3,824   3,824    
Employee Stock Purchase Plan issuance 121   121    
Employee Stock Purchase Plan issuance, Shares   24,214      
Stock option exercises 56   56    
Stock option exercises, Shares   12,733      
Common stock warrant exercises 123   123    
Common stock warrant exercises, Shares   25,000      
Vesting of restricted stock, Shares   500,744      
Unrealized loss on marketable securities (78)       (78)
Currency translation adjustment (27)       (27)
Net loss (33,685)     (33,685)  
Ending Balance at Mar. 31, 2026 $ 107,247   $ 621,557 $ (514,103) $ (207)
Ending Balance, Shares at Mar. 31, 2026   64,150,468